FI840301A0 - Rebeccamycin och foerfarande foer dess framstaellning - Google Patents

Rebeccamycin och foerfarande foer dess framstaellning

Info

Publication number
FI840301A0
FI840301A0 FI840301A FI840301A FI840301A0 FI 840301 A0 FI840301 A0 FI 840301A0 FI 840301 A FI840301 A FI 840301A FI 840301 A FI840301 A FI 840301A FI 840301 A0 FI840301 A0 FI 840301A0
Authority
FI
Finland
Prior art keywords
rebeccamycin
foerfarande foer
och foerfarande
foer dess
dess framstaellning
Prior art date
Application number
FI840301A
Other languages
English (en)
Other versions
FI77264C (fi
FI77264B (fi
FI840301A (fi
Inventor
Jr Donald Edward Nettleton
James Allen Bush
William Turnbull Bradner
Terrence William Doyle
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI840301A0 publication Critical patent/FI840301A0/fi
Publication of FI840301A publication Critical patent/FI840301A/fi
Priority to FI882363A priority Critical patent/FI80047C/fi
Application granted granted Critical
Publication of FI77264B publication Critical patent/FI77264B/fi
Publication of FI77264C publication Critical patent/FI77264C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI840301A 1983-01-28 1984-01-25 Foerfarande foer framstaellning av rebeccamycin med antitumoer effekt. FI77264C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI882363A FI80047C (fi) 1983-01-28 1988-05-19 Foerfarande foer framstaellning av rebeccamycinderivat.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46181783 1983-01-28
US06/461,817 US4487925A (en) 1983-01-28 1983-01-28 Rebeccamycin and process for its preparation

Publications (4)

Publication Number Publication Date
FI840301A0 true FI840301A0 (fi) 1984-01-25
FI840301A FI840301A (fi) 1984-07-29
FI77264B FI77264B (fi) 1988-10-31
FI77264C FI77264C (fi) 1989-02-10

Family

ID=23834041

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840301A FI77264C (fi) 1983-01-28 1984-01-25 Foerfarande foer framstaellning av rebeccamycin med antitumoer effekt.

Country Status (15)

Country Link
US (1) US4487925A (fi)
EP (1) EP0115350B1 (fi)
JP (1) JPS59141597A (fi)
KR (1) KR910002856B1 (fi)
AT (1) ATE36540T1 (fi)
AU (1) AU564256B2 (fi)
CA (1) CA1220149A (fi)
DE (1) DE3473459D1 (fi)
DK (1) DK160429C (fi)
ES (1) ES8607396A1 (fi)
FI (1) FI77264C (fi)
GR (1) GR81748B (fi)
IE (1) IE56651B1 (fi)
PT (1) PT78019B (fi)
ZA (1) ZA84582B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
US4764510A (en) * 1986-04-11 1988-08-16 Eli Lilly And Company Antibiotic A42125 and process for its production
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
WO1993018766A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6855698B2 (en) 2001-03-22 2005-02-15 Bristol-Myers Squibb Company Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
FR2956934B1 (fr) 2010-02-26 2012-09-28 Blink E Procede et dispositif d'emission/reception de signaux electromagnetiques recus/emis sur une ou plusieurs premieres bandes de frequences.
FR2990315B1 (fr) 2012-05-04 2014-06-13 Blink E Procede de transmission d'informations entre une unite emettrice et une unite receptrice

Also Published As

Publication number Publication date
GR81748B (fi) 1984-12-12
ATE36540T1 (de) 1988-09-15
EP0115350A3 (en) 1985-09-18
DK160429C (da) 1991-08-19
IE840201L (en) 1984-07-28
DE3473459D1 (en) 1988-09-22
EP0115350B1 (en) 1988-08-17
AU564256B2 (en) 1987-08-06
DK160429B (da) 1991-03-11
IE56651B1 (en) 1991-10-23
FI77264C (fi) 1989-02-10
PT78019B (en) 1986-06-18
KR910002856B1 (ko) 1991-05-06
CA1220149A (en) 1987-04-07
FI77264B (fi) 1988-10-31
JPH0452280B2 (fi) 1992-08-21
EP0115350A2 (en) 1984-08-08
ES8607396A1 (es) 1986-05-16
KR840007257A (ko) 1984-12-06
ZA84582B (en) 1984-09-26
PT78019A (en) 1984-02-01
FI840301A (fi) 1984-07-29
JPS59141597A (ja) 1984-08-14
DK35684D0 (da) 1984-01-26
US4487925A (en) 1984-12-11
DK35684A (da) 1984-07-29
ES529170A0 (es) 1986-05-16
AU2372084A (en) 1984-08-02

Similar Documents

Publication Publication Date Title
FI840301A (fi) Rebeccamycin och foerfarande foer dess framstaellning.
ES2061416T1 (es) Ribocimas modificadas.
ES2143620T3 (es) Polipeptidos modificados con actividad biologica incrementada.
ATE62249T1 (de) Homodisaccharide hypoglycemische mittel.
GB1510925A (en) Chromogenic enzyme substrates
GB1481927A (en) Imidazodiazepine derivative
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
AU570142B2 (en) Purine derivatives
EP0513067A4 (en) A pratical synthesis of 2'-deoxynucleosides and 2',3'-dideoxy-2',3'-didehydronucleosides
SE8202439L (sv) 4'-jodderivat av antracyklinglykosider
SE8502135D0 (sv) 4'-deschlororebeccamycin and process for its preparation
SG18792G (en) Drug preparations of reduced toxicity
AU6311386A (en) Appetite moderating and anti-gastritis conposition
AU8192382A (en) Modified microorganism to produce interferon like activity
AU685022B2 (en) Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
BE872913A (fr) Nouveaux derives de type n-acyl-4, n-acyl-2, et n,n'diacyl-4,2 fortimicine e.
SE8402619D0 (sv) Bbm-1675, a new antitumor antibiotic complex
NO913118D0 (no) T-pa pro stabilisering.
FR2401172A1 (fr) Nouvel antibiotique antitumoral obtenu a partir d'un filtrat de bouillon de culture de streptomyces macromomyceticus
IE39496B1 (en) 5"-amino-4,5"-dideoxy/ambutyrosin a
GB1492454A (en) Use of amino-sugar derivatives in animal nutrition
JPS6461494A (en) Production of 5'-0-acyl-5-fluorouridine derivative
NZ180300A (en) Antibiotic 32,999 rp produced by microbiological reduction and by cultivation of streptomyces coeruleorubidus(nrrl 3046,nrrl o045nrrl 8098)strepthomyces bifurcus(nrrl3539)andstreptomyces atroviolaceus(nrrl 8148)
GB1464401A (en) Aminoglycosides
IL86824A (en) Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS CO